| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 2005;79:1072-1080
© 2005 The Society of Thoracic Surgeons
a Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, the Harvard-MIT Division of Health Sciences and Technology, Boston, Massachusetts
b Abramson Pediatric Research Center, The Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, Pennsylvania
* Address reprint requests to Dr Schoen, Department of Pathology, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115 (E-mail: fschoen{at}partners.org).
Calcification plays a major role in the failure of bioprosthetic and other tissue heart valve substitutes. Tissue valve calcification is initiated primarily within residual cells that have been devitalized, usually by glutaraldehyde pretreatment. The mechanism involves reaction of calcium-containing extracellular fluid with membrane-associated phosphorus to yield calcium phosphate mineral deposits. Calcification is accelerated by young recipient age, valve factors such as glutaraldehyde fixation, and increased mechanical stress. Recent studies have suggested that pathologic calcification is regulated by inductive and inhibitory factors, similar to the physiologic mineralization of bone. The most promising preventive strategies have included binding of calcification inhibitors to glutaraldehyde fixed tissue, removal or modification of calcifiable components, modification of glutaraldehyde fixation, and use of tissue cross linking agents other than glutaraldehyde. This review summarizes current concepts in the pathophysiology of tissue valve calcification, including emerging concepts of endogenous regulation, progress toward prevention of calcification, and issues related to calcification of the aortic wall of stentless bioprosthetic valves.
Related Article
Ann. Thorac. Surg. 2005 79: 905-910.
This article has been cited by other articles:
|
|
 |
|
  J. Leong, A. Munnelly, B. Liberio, L. Cochrane, and N. Vyavahare Neomycin and carbodiimide crosslinking as an alternative to glutaraldehyde for enhanced durability of bioprosthetic heart valves J Biomater Appl, May 1, 2013; 27(8): 948 - 960. [Abstract] [PDF]
|
|
|
|
 |
|
 C. Convelbo, P. Guetat, M. Cambillau, B. Allam, P. Bruneval, A. Lafont, and R. Zegdi Crimping and deployment of balloon-expandable valved stents are responsible for the increase in the hydraulic conductance of leaflets Eur J Cardiothorac Surg, April 3, 2013; (2013) ezt175v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Hechadi, B. L. Gerber, E. Coche, J. Melchior, R. Jashari, D. Glineur, P. Noirhomme, J. Rubay, G. El Khoury, and L. De Kerchove Stentless xenografts as an alternative to pulmonary homografts in the Ross operation Eur J Cardiothorac Surg, March 18, 2013; (2013) ezt147v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-Y. S. Huang, B. N. Balhouse, and S. Huang Application of simple biomechanical and biochemical tests to heart valve leaflets: Implications for heart valve characterization and tissue engineering Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine, November 1, 2012; 226(11): 868 - 876. [Abstract] [PDF]
|
|
|
|
 |
|
 J. A. Leopold Cellular Mechanisms of Aortic Valve Calcification Circ Cardiovasc Interv, August 1, 2012; 5(4): 605 - 614. [Full Text] [PDF]
|
|
|
|
|
|
C. Lee, H. Ahn, S. H. Kim, S. Y. Choi, and Y. J. Kim Immune response to bovine pericardium implanted into {alpha}1,3-galactosyltransferase knockout mice: feasibility as an animal model for testing efficacy of anticalcification treatments of xenografts Eur J Cardiothorac Surg, July 1, 2012; 42(1): 164 - 172. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. de Buhr, S. Pfeifer, J. Slotta-Huspenina, E. Wintermantel, G. Lutter, and W. A. Goetz Impairment of pericardial leaflet structure from balloon-expanded valved stents J. Thorac. Cardiovasc. Surg., June 1, 2012; 143(6): 1417 - 1421. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Jansen, W. van Oeveren, A. Capel, and A. Carpentier In vitro haemocompatibility of a novel bioprosthetic total artificial heart Eur J Cardiothorac Surg, June 1, 2012; 41(6): e166 - e172. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Funder Current status on stentless aortic bioprosthesis: a clinical and experimental perspective Eur J Cardiothorac Surg, April 1, 2012; 41(4): 790 - 799. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-G. Lim, S. H. Kim, S. Y. Choi, and Y. J. Kim Anticalcification effects of decellularization, solvent, and detoxification treatment for genipin and glutaraldehyde fixation of bovine pericardium Eur J Cardiothorac Surg, February 1, 2012; 41(2): 383 - 390. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Sinha, D. Zurakowski, T. K. Susheel Kumar, D. He, C. Rossi, and R. A. Jonas Effects of glutaraldehyde concentration, pretreatment time, and type of tissue (porcine versus bovine) on postimplantation calcification J. Thorac. Cardiovasc. Surg., January 1, 2012; 143(1): 224 - 227. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Weber, J. Scherman, M. Y. Emmert, J. Gruenenfelder, R. Verbeek, M. Bracher, M. Black, J. Kortsmit, T. Franz, R. Schoenauer, et al. Injectable living marrow stromal cell-based autologous tissue engineered heart valves: first experiences with a one-step intervention in primates Eur. Heart J., November 2, 2011; 32(22): 2830 - 2840. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Butany, T. Feng, A. Luk, K. Law, R. Suri, and V. Nair Modes of Failure in Explanted Mitroflow Pericardial Valves Ann. Thorac. Surg., November 1, 2011; 92(5): 1621 - 1627. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Connolly, M. A. Bakay, I. S. Alferiev, R. C. Gorman, J. H. Gorman III, H. S. Kruth, P. E. Ashworth, J. K. Kutty, F. J. Schoen, R. W. Bianco, et al. Triglycidyl Amine Crosslinking Combined With Ethanol Inhibits Bioprosthetic Heart Valve Calcification Ann. Thorac. Surg., September 1, 2011; 92(3): 858 - 865. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-H. Chen and C. A. Simmons Cell-Matrix Interactions in the Pathobiology of Calcific Aortic Valve Disease: Critical Roles for Matricellular, Matricrine, and Matrix Mechanics Cues Circ. Res., June 10, 2011; 108(12): 1510 - 1524. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Honge, J. Funder, E. Hansen, P. M. Dohmen, W. Konertz, and J. M. Hasenkam Recellularization of aortic valves in pigs Eur J Cardiothorac Surg, June 1, 2011; 39(6): 829 - 834. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. W. Chang, S. H. Kim, K.-H. Kim, and Y. J. Kim Combined anti-calcification treatment of bovine pericardium with amino compounds and solvents Interact CardioVasc Thorac Surg, June 1, 2011; 12(6): 903 - 907. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Mathapati, R. S. Verma, K. M. Cherian, and S. Guhathakurta Inflammatory responses of tissue-engineered xenografts in a clinical scenario Interact CardioVasc Thorac Surg, March 1, 2011; 12(3): 360 - 365. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Lee, S. H. Kim, S.-H. Choi, and Y. J. Kim High-concentration glutaraldehyde fixation of bovine pericardium in organic solvent and post-fixation glycine treatment: in vitro material assessment and in vivo anticalcification effect Eur J Cardiothorac Surg, March 1, 2011; 39(3): 381 - 387. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Wei, W. Yi, W. Chen, X. Ma, W. B. Lau, H. Wang, and D. Yi Clinical Outcomes With the Epicholorohydrin-Modified Porcine Aortic Heart Valve: A 15-Year Follow-Up Ann. Thorac. Surg., May 1, 2010; 89(5): 1417 - 1424. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. M.S. Shrestha, S. Fukushima, M. Vrtik, I. H. Chong, L. Sparks, H. Jalali, and P. G. Pohlner Partial Replacement of Tricuspid Valve Using Cryopreserved Homograft Ann. Thorac. Surg., April 1, 2010; 89(4): 1187 - 1194. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Wiedemann, N. Bonaros, G. Laufer, and A. Kocher Aortic Bioprosthetic Valve Deterioration 8 Months After Implantation Ann. Thorac. Surg., January 1, 2010; 89(1): 277 - 279. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Verbrugghe, B. Meuris, W. Flameng, and P. Herijgers Reconstruction of atrioventricular valves with photo-oxidized bovine pericardium Interact CardioVasc Thorac Surg, November 1, 2009; 9(5): 775 - 779. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Tudorache, S. Kostin, T. Meyer, O. Teebken, C. Bara, A. Hilfiker, A. Haverich, and S. Cebotari Viable vascularized autologous patch for transmural myocardial reconstruction, Eur J Cardiothorac Surg, August 1, 2009; 36(2): 306 - 311. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Caprili, A. N. Fahim, C. Zussa, and D. M. Cristell Very early malfunction of a large stentless aortic valve Eur J Cardiothorac Surg, August 1, 2009; 36(2): 417 - 418. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Y. Chen, J. Hermiller, A. K. Sinha, M. Sturek, L. Zhu, and G. S. Kassab Effects of stent sizing on endothelial and vessel wall stress: potential mechanisms for in-stent restenosis J Appl Physiol, May 1, 2009; 106(5): 1686 - 1691. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kalejs, P. Stradins, R. Lacis, I. Ozolanta, J. Pavars, and V. Kasyanov St Jude Epic heart valve bioprostheses versus native human and porcine aortic valves - comparison of mechanical properties Interact CardioVasc Thorac Surg, May 1, 2009; 8(5): 553 - 556. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Pibarot and J. G. Dumesnil Prosthetic Heart Valves: Selection of the Optimal Prosthesis and Long-Term Management Circulation, February 24, 2009; 119(7): 1034 - 1048. [Full Text] [PDF]
|
|
|
|
 |
|
 E. L. Monzack, X. Gu, and K. S. Masters Efficacy of Simvastatin Treatment of Valvular Interstitial Cells Varies With the Extracellular Environment Arterioscler Thromb Vasc Biol, February 1, 2009; 29(2): 246 - 253. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. J. Schoen Evolving Concepts of Cardiac Valve Dynamics: The Continuum of Development, Functional Structure, Pathobiology, and Tissue Engineering Circulation, October 28, 2008; 118(18): 1864 - 1880. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Izutani, T. Shibukawa, J. Kawamoto, S. Mochiduki, and D. Nishikawa Early Aortic Bioprosthetic Valve Deterioration in an Octogenarian Ann. Thorac. Surg., October 1, 2008; 86(4): 1369 - 1371. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Pettenazzo, M. Valente, and G. Thiene Octanediol treatment of glutaraldehyde fixed bovine pericardium: evidence of anticalcification efficacy in the subcutaneous rat model Eur J Cardiothorac Surg, August 1, 2008; 34(2): 418 - 422. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Fiore, M. Rodefeld, M. Turrentine, P. Vijay, T. Reynolds, J. Standeven, K. Hill, J. Bost, D. Carpenter, C. Tobin, et al. Pulmonary Valve Replacement: A Comparison of Three Biological Valves Ann. Thorac. Surg., May 1, 2008; 85(5): 1712 - 1718. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. A. Goetz, T. E. Tan, K. H. Lim, S. L. H. Salgues, N. Grousson, F. Xiong, Y. L. Chua, and J. H. Yeo Truly stentless molded autologous pericardial aortic valve prosthesis with single point attached commissures in a sheep model Eur J Cardiothorac Surg, April 1, 2008; 33(4): 548 - 553. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Walther, J. Kempfert, M. A. Borger, J. Fassl, V. Falk, J. Blumenstein, M. Dehdashtian, G. Schuler, and F. W. Mohr Human Minimally Invasive Off-Pump Valve-in-a-Valve Implantation Ann. Thorac. Surg., March 1, 2008; 85(3): 1072 - 1073. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. F. Padera Jr. and F. J. Schoen Pathology of Cardiac Surgery , January 1, 2008; 3(2008): 111 - 178. [Full Text]
|
|
|
|
 |
|
 P. C. Santos, L. R. Gerola, I. Casagrande, E. Buffolo, and D. T. Cheung Stentless Valves Treated by the L-Hydro Process in the Aortic Position in Sheep Asian Cardiovascular and Thoracic Annals, October 1, 2007; 15(5): 413 - 417. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Weber, J. Jouan, A. Matsunaga, E. Pettenazzo, T. Joudinaud, G. Thiene, and C. M.G. Duran Evidence of mitigated calcification of the Mosaic versus Hancock Standard valve xenograft in the mitral position of young sheep. J. Thorac. Cardiovasc. Surg., November 1, 2006; 132(5): 1137 - 1143. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Cebotari, A. Lichtenberg, I. Tudorache, A. Hilfiker, H. Mertsching, R. Leyh, T. Breymann, K. Kallenbach, L. Maniuc, A. Batrinac, et al. Clinical Application of Tissue Engineered Human Heart Valves Using Autologous Progenitor Cells Circulation, July 4, 2006; 114(1_suppl): I-132 - I-137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Vesely Heart Valve Tissue Engineering Circ. Res., October 14, 2005; 97(8): 743 - 755. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
